JayJenshongLinMD

PubMed

• 5 citations
  Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients
  Amol D Dhamane, Christine L. Baker, Jigar Rajpura, Jack Mardekian, Oluwaseyi Dina, Cristina Russ, Lisa Rosenblatt, Melissa Lingohr-Smith, Jay Lin> ;Current Medical Research and Opinion. 2019 Jun 5
• 9 citations
  Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.
  Alpesh Amin, Steven Deitelzweig, Iwona Bucior, Jay Lin, Melissa Lingohr-Smith, Brandy Menges, W. Richey Neuman> ;Journal of Medical Economics. 2019 Jun 4
• 9 citations
  Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US.
  Elias Jabbour, Martin F Mendiola, Melissa Lingohr-Smith, Jay Lin, Dinara Makenbaeva> ;Journal of Medical Economics. 2019 May 31
• 1 citations
  Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States.
  Elias Jabbour, Lisa R. Siegartel, Jay Lin, Melissa Lingohr-Smith, Brandy Menges, Dinara Makenbaeva> ;Leukemia & Lymphoma. 2019 Feb 23
• 17 citations
  Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illn...
  Alpesh Amin, W. Richey Neuman, Melissa Lingohr-Smith, Brandy Menges, Jay Lin> ;Drugs in Context. 2019 Jan 21
• 5 citations
  Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
  Alpesh Amin, W. Richey Neuman, Melissa Lingohr-Smith, Brandy Menges, Jay Lin> ;Clinical and Applied Thrombosis/hemostasis. 2019 Jan 1
• 5 citations
  Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis
  Alpesh Amin, W. Richey Neuman, Melissa Lingohr-Smith, Brandy Menges, Jay Lin> ;Advances in Therapy. 2019 Jan 1
• 2 citations
  Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
  Seema Patil, Mark Flasar, Jay Lin, Melissa Lingohr-Smith, Martha Skup, Song Wang, Jingdong Chao, Raymond K. Cross> ;Digestive Diseases and Sciences. 2019 Jan 1
• 2 citations
  Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
  Steven Deitelzweig, Jennifer D Guo, Patrick Hlavacek, Jay Lin, Gail Wygant, Lisa Rosenblatt, Anu Gupta, Xianying Pan, Jack Mardekian, Melissa Lingohr-Smith, Brandy Men...> ;Clinical and Applied Thrombosis/hemostasis. 2018 Nov 15
• 7 citations
  Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic model
  Elias Jabbour, Lisa R. Siegartel, Jay Lin, Melissa Lingohr-Smith, Brandy Menges, Dinara Makenbaeva> ;Journal of Medical Economics. 2018 Aug 15
• 4 citations
  Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States
  Steven R. Feldman, Shipra Rastogi, Jay Lin> ;Dermatology and Therapy. 2018 Jul 13
• 22 citations
  Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
  Jashin J. Wu, Steven R. Feldman, Shipra Rastogi, Brandy Menges, Melissa Lingohr-Smith, Jay Lin> ;The Journal of Dermatological Treatment. 2018 May 7
• 5 citations
  Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States
  Steven Deitelzweig, Michael A. Evans, Jeffrey Trocio, Kiran Gupta, Melissa Lingohr-Smith, Brandy Menges, Jay Lin> ;Clinical and Applied Thrombosis/hemostasis. 2018 Mar 1
• 2 citations
  The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
  Steven R. Feldman, Jashin J. Wu, Shipra Rastogi, Brandy Menges, Melissa Lingohr-Smith, Jay Lin> ;Journal of Medical Economics. 2018 Feb 2
• 7 citations
  All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Antico...
  S. Deitelzweig, Xuemei Luo, Kiran Gupta, Jeffrey Trocio, Jack Mardekian, Tammy Curtice, Patrick Hlavacek, Melissa Lingohr-Smith, Brandy Menges, Jay Lin> ;Clinical and Applied Thrombosis/hemostasis. 2018 Jan 24
• 30 citations
  DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
  Jay Lin, Steve Zhou, Wenhui Wei, Chunshen Pan, Melissa Lingohr-Smith, Philip Levin> ;Endocrine Practice. 2016 Feb 1
• 9 citations
  Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation
  Steve Deitelzweig, Michael A. Evans, Eric Hillson, Jeffrey Trocio, Amanda Bruno, Wilson Tan, Melissa Lingohr-Smith, Prianka Singh, Jay Lin> ;Current Medical Research and Opinion. 2016 Jan 2
• 36 citations
  An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants
  Steve Deitelzweig, Amanda Bruno, Jeffrey Trocio, Natalie Tate, Kiran Gupta, Jay Lin, Melissa Lingohr-Smith> ;Current Medical Research and Opinion. 2016 Jan 1
• 8 citations
  Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results.
  Alpesh Amin, Yonghua Jing, Jeffrey Trocio, Jay Lin, Melissa Lingohr-Smith, John Graham> ;Journal of Thrombosis and Thrombolysis. 2015 Aug 1
• 27 citations
  Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thrombo...
  Alpesh Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin, Melissa Lingohr-Smith> ;Journal of Medical Economics. 2015 Jan 14
• Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedaron...
  Matthew R. Reynolds, Jay Lin, Mehul Jhaveri, Essy Mozaffari, Adam Plich> ;American Journal of Therapeutics. 2014 Nov 1
• 15 citations
  Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients.
  Alpesh Amin, Yonghua Jing, Jeffrey Trocio, Jay Lin, Melissa Lingohr-Smith, John Graham> ;Journal of Medical Economics. 2014 Jul 31
• 2 citations
  Health Care Burden of Dyspepsia Among Nonvalvular Atrial Fibrillation Patients
  Michael H. Kim, Kelly F Bell, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham> ;Journal of Managed Care & Specialty Pharmacy. 2014 Apr 1
• 4 citations
  Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
  Michael H. Kim, Jay Lin, Mehul Jhaveri, Andrew Koren> ;Advances in Therapy. 2014 Mar 5
• 50 citations
  Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with nov...
  Alpesh Amin, Steve Deitelzweig, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham> ;Journal of Thrombosis and Thrombolysis. 2014 Jan 30
• Join now to see all